Pharmacogenomics Resources of Interest
The Consortium conducts original research, serves students and faculty, and advances public dialogue and understanding on emerging issues at the intersection of science and society.
Develop, validate, and maintain state of the art quantitative assays to support research and clinical care for researchers and clinicians. Expertise in pharmacology, pharmacokinetics, pharmacodynamics, genetics, and genomics to help investigators develop scientific protocols and to help clinicians optimize drug therapy in patients.
The newly established Epigenetics Consortium at the University of Minnesota aims to strengthen the epigenetics research at our university and establish the UMN as a major key player in this important field.
Bringing together scientists, healthcare providers, patients and payers in the area of precision medicine to promote research, education and the use of precision medicine and health to improve human health.
The Genomics Center provides genomics research services committed to advancing genomics in Minnesota. The UMGC maintains and acquires state-of-the-art instrumentation and offers an array of services including sequencing, expression, genotyping, nucleic acid extraction and related support
Home site for PGx gene nomenclature and serves as a centralized "Next-Generation" Pharmacogene Variation data repository
The Single Nucleotide Polymorphism database (dbSNP) is a public-domain archive for a broad collection of simple genetic polymorphisms.
The table from FDA’s website listing FDA-approved drugs with pharmacogenomic information in their labels.
The goal of the International HapMap Project is to develop a haplotype map of the human genome, the HapMap, which will describe the common patterns of human DNA sequence variation. The HapMap is expected to be a key resource for researchers to use to find genes affecting health, disease, and responses to drugs and environmental factors.
iGeneTRAIN aims to coordinate genetic and other patient data and expertise from sites across the world engaged in clinical and research transplant programs.
The mission of the Pharmacogenomics Research Network (PGRN) is to catalyze and lead research in precision medicine for the discovery and translation of genomic variation influencing therapeutic and adverse drug effects. To this end, the PGRN hosts various activities that stimulate collaborative research in pharmacogenomics and precision medicine.
The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including dosing guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships.
These dosing guidelines take into consideration patient genotype and have been published by the Clinical Pharmacogenetics Implementation Consortium CPIC, the Royal Dutch Association for the Advancement of Pharmacy - Pharmacogenetics Working Group DPWG (manually curated by PharmGKB), or other professional society PRO (manually curated by PharmGKB).
This is an online, searchable database of published scientific literature, CDC resources, and other material that addresses the translation of genomic discoveries into improved health care and disease prevention.
EU-Pic's purpose is to implement and support Pharmacogenetics for the most important and actionable pharmacogenetic markers into clinical care, and to monitor uptake and experiences.